{"organizations": [], "uuid": "c8d8c0952057924133900c5d68f357adeaafd9a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shanxi-zhendong-pharmaceutical-see/brief-shanxi-zhendong-pharmaceutical-sees-fy-2017-net-profit-up-55-pct-to-70-pct-idUSL4N1PJ2HT", "country": "US", "domain_rank": 408, "title": "BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 net profit up 55 pct to 70 pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.993, "site_type": "news", "published": "2018-01-24T14:33:00.000+02:00", "replies_count": 0, "uuid": "c8d8c0952057924133900c5d68f357adeaafd9a7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shanxi-zhendong-pharmaceutical-see/brief-shanxi-zhendong-pharmaceutical-sees-fy-2017-net-profit-up-55-pct-to-70-pct-idUSL4N1PJ2HT", "ord_in_thread": 0, "title": "BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 net profit up 55 pct to 70 pct", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-shanxi zhendong pharmaceutical", "sentiment": "negative"}, {"name": "reuters) - shanxi zhendong pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24(Reuters) - Shanxi Zhendong Pharmaceutical Co Ltd\n* Sees FY 2017 net profit to increase by 55 percent to 70 percent, or to be 314.7 million yuan to 345.2 million yuan\n* Says FY 2016 net profit was 203.1 million yuan\n* Says increased income from pharmaceutical unit is the main reason for the forecast\nSource text in Chinese: goo.gl/HpSozU\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/HpSozU"], "published": "2018-01-24T14:33:00.000+02:00", "crawled": "2018-01-25T13:14:17.014+02:00", "highlightTitle": ""}